Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury.
Chaturvedi S, Yuen DA, Bajwa A, Huang YW, Sokollik C, Huang L, Lam GY, Tole S, Liu GY, Pan J, Chan L, Sokolskyy Y, Puthia M, Godaly G, John R, Wang C, Lee WL, Brumell JH, Okusa MD, Robinson LA. Chaturvedi S, et al. Among authors: tole s. J Am Soc Nephrol. 2013 Jul;24(8):1274-87. doi: 10.1681/ASN.2012090890. Epub 2013 Jun 13. J Am Soc Nephrol. 2013. PMID: 23766538 Free PMC article.
Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation.
Quinn KL, Henriques M, Tabuchi A, Han B, Yang H, Cheng WE, Tole S, Yu H, Luo A, Charbonney E, Tullis E, Lazarus A, Robinson LA, Ni H, Peterson BR, Kuebler WM, Slutsky AS, Zhang H. Quinn KL, et al. Among authors: tole s. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2070-9. doi: 10.1161/ATVBAHA.111.227116. Epub 2011 Aug 4. Arterioscler Thromb Vasc Biol. 2011. PMID: 21817096 Free PMC article.
The cell motility modulator Slit2 is a potent inhibitor of platelet function.
Patel S, Huang YW, Reheman A, Pluthero FG, Chaturvedi S, Mukovozov IM, Tole S, Liu GY, Li L, Durocher Y, Ni H, Kahr WH, Robinson LA. Patel S, et al. Among authors: tole s. Circulation. 2012 Sep 11;126(11):1385-95. doi: 10.1161/CIRCULATIONAHA.112.105452. Epub 2012 Aug 3. Circulation. 2012. PMID: 22865890
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.
Malec L, Peyvandi F, Chan AKC, Königs C, Zulfikar B, Yuan H, Simpson M, Álvarez Román MT, Carcao M, Staber JM, Dunn AL, Chou SC, d'Oiron R, Albisetti M, Demissie M, Santagostino E, Yarramaneni A, Wong N, Abad-Franch L, Gunawardena S, Fijnvandraat K; XTEND-Kids Trial Group. Malec L, et al. N Engl J Med. 2024 Jul 18;391(3):235-246. doi: 10.1056/NEJMoa2312611. N Engl J Med. 2024. PMID: 39018533 Clinical Trial.
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.
Kirpalani A, Garabon J, Amos K, Patel S, Sharma AP, Ganesan SL, Barton M, Cacciotti C, Leppington S, Bakovic L, Huang SS, Knauer MJ, Tole S. Kirpalani A, et al. Among authors: tole s. Br J Haematol. 2022 Jan;196(1):e11-e14. doi: 10.1111/bjh.17782. Epub 2021 Aug 17. Br J Haematol. 2022. PMID: 34405400 Free PMC article. No abstract available.
118 results